Teladoc Health (NYSE:TDOC) Shares Gap Up – Still a Buy?

Teladoc Health, Inc. (NYSE:TDOC) gapped up before the market opened on Monday . The stock had previously closed at $10.62, but opened at $11.14. Teladoc Health shares last traded at $11.34, with a volume of 305,390 shares.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. The Goldman Sachs Group started coverage on Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 target price for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. Jefferies Financial Group increased their price target on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a report on Tuesday, September 17th. Stifel Nicolaus reduced their price target on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. decreased their price objective on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a report on Monday, August 26th. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $12.08.

Teladoc Health Stock Performance

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm’s 50 day moving average price is $9.18 and its 200-day moving average price is $9.25.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Buying and Selling

In other Teladoc Health news, Director Thomas Mckinley acquired 4,000 shares of Teladoc Health stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now directly owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. This represents a 11.40 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the transaction, the chief operating officer now owns 78,309 shares of the company’s stock, valued at $560,692.44. This represents a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,051 shares of company stock worth $143,565. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after buying an additional 228,004 shares in the last quarter. Clearline Capital LP grew its stake in Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock valued at $42,682,000 after acquiring an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Teladoc Health by 195.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider’s stock worth $932,000 after acquiring an additional 63,028 shares in the last quarter. Jennison Associates LLC acquired a new position in Teladoc Health during the third quarter worth $1,544,000. Finally, Mackenzie Financial Corp lifted its holdings in Teladoc Health by 170.7% during the second quarter. Mackenzie Financial Corp now owns 107,255 shares of the health services provider’s stock valued at $1,049,000 after purchasing an additional 67,640 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.